Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

Viscosizer 200

Product Description
The Viscosizer 200 is an innovation in automated viscosity measurement and molecular sizing using very small sample volumes. This new technology is driven by UV area imaging, and at its heart is a unique dual-pass capillary system, with two detection windows removing any injection time error. This instrument is ideally placed to serve those working within biopharmaceutical preformulation and formulation development, who need rapid viscosity information on a large number of low volume samples, in order to assess candidate developability.

The Viscosizer 200 is a new and unique viscosity and size analysis system which is capable of accurate, reproducible measurement of viscosity in sample volumes as low as 10µL. It can also perform a separate size analysis of particles in sample volumes as low as 10nL.

This is a dual-pass microcapillary-based instrument, supplied by a carousel autosampler which allows automated, high throughput sample delivery. It differs from other capillary-based viscometers in that it has two windows burned into the capillary, at each of which UV area imaging of absorbance in the sample takes place. Both size and viscosity analyses are based on time-based changes which occur between the two windows, eliminating the error associated with imprecision in sample injection time in other capillary-based viscometers.

The Viscosizer 200 is adaptable to a wide variety of uses, but is particularly well-positioned to assist in preformulation studies, where sample numbers are high but volumes are very low. It can rapidly provide vital information on the viscosities of a range of formulations at a much earlier stage than previously possible, enabling quick detection of potentially problematic samples and dramatically reducing risk on investment in development.

The system also enables sizing of UV-active molecules present within complex formulations or matrices, lending itself to a range of applications, including the measurement of proteins and small molecules within excipient-laden formulations.

Accurate, automated measurement of viscosity in the range 0.9 cP to 120 cP by UV Area Imaging.
Sample volume of less than 10 µL required for viscosity analysis.
Precise mass-weighted hydrodynamic sizing of selected particles in the range 0.2 nm to 100 nm radius by Taylor Dispersion Analysis.
Sample volume of less than 10 nL required for sizing.
Rapid batch analysis using the 45-position carousel autosampler.
Sizing of UV-active particles can be performed even within complex formulations.
Enclosed microcapillary geometry free of interfacial effects.
Highly reproducible results.
Wide range of working concentrations.
User-selectable incident light wavelength.
Intuitive and flexible Malvern software package.
Product Viscosizer 200
Company Malvern Instruments Limited
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Malvern Instruments Limited
Grovewood Road Malvern Worcestershire WR14 1XZ UK

Tel: +44 (0) 1684 892456
Fax: +44 (0) 1684 892789

Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos